Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | MMP2 | P08253 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | MMP1 | P03956 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | MMP8 | P22894 | 1/20 | 0.56 |
| ▸ | MMP13 | P45452 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.51 |
| ▸ | MMP14 | P50281 | 1/20 | 0.50 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5605338 | 0.98 | CA2 (0.54) | CA2MMP2CA1MMP1MMP9 | |
| SCHEMBL29176138 | 0.92 | HTR6 (0.52) | CA2MMP2CA1MMP1MMP9 | |
| Ether SCHEMBL11029157 | 0.86 | KDM4E (0.50) | CA2MMP2PTGS2PTGS1KDM4E | |
| SCHEMBL3928655 | 0.83 | CA2 (0.52) | CA2MMP2CA1MMP1MMP9 | |
| SCHEMBL6012074 | 0.82 | CA2 (0.60) | CA2MMP2CA1MMP1MMP9 | |
| SCHEMBL10931933 | 0.82 | CA2 (0.60) | CA2MMP2CA1MMP1MMP9 | |
| SCHEMBL453442 | 0.82 | CA2 (0.60) | CA2MMP2CA1MMP1MMP9 | |
| Sulfacarbamide SCHEMBL8024629 | 0.81 | KMT2A (0.69) | CA2MMP2CA1MMP1MMP9 | |
| SCHEMBL29030151 | 0.81 | BCAT1 (0.43) | CA2MMP2CA1MMP1MMP9 | |
| SCHEMBL1269819 | 0.81 | CA2 (0.54) | CA2MMP2CA1MMP1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1087 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120059262-A | Material for thermal printing wrist strap and preparation method thereof | 中裕(惠州)科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-116813522-A | Preparation method and application of indole-containing benzenesulfonyl urea compound | 广州方中化工有限公司 | 2023-09-29 | — | — | CN | claimed |
| US-20230301946-A1 | THROMBOXANE RECEPTOR ANTAGONIST FORMULATIONS | ATXA THERAPEUTICS LIMITED (IE) | 2023-09-28 | — | — | US | claimed |
| CN-116601149-A | Aminoquinazoline derivatives as P2X3 inhibitors | 奇斯药制品公司 | 2023-08-15 | — | — | CN | claimed |
| CN-116234539-A | Thrombus receptor antagonist formulations | ATXA治疗有限公司 | 2023-06-06 | — | — | CN | claimed |
| EP-4178547-A1 | THROMBOXANE RECEPTOR ANTAGONIST FORMULATIONS | ATXA Therapeutics Limited (IE) | 2023-05-17 | — | — | EP | claimed |
| CN-112210164-B | Polyolefin material and preparation method thereof | 金发科技股份有限公司 | 2023-03-21 | — | — | CN | claimed |
| US-20220233501-A1 | THERAPEUTIC COMBINATIONS | SUPERSALUS INC (US) | 2022-07-28 | — | — | US | claimed |
| CN-114766485-A | Application of semi-rigid acylhydrazone ligand in herbicide and composite herbicide based on semi-rigid acylhydrazone ligand | 兰州大学 | 2022-07-22 | — | — | CN | claimed |
| WO-2022008515-A1 | THROMBOXANE RECEPTOR ANTAGONIST FORMULATIONS | ATXA THERAPEUTICS LIMITED (IE) | 2022-01-13 | — | — | WO | claimed |
| EP-0006587-B1 | SULFONYL UREAS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-11-11 | — | — | EP | claimed |
| US-4157395-A | TREATMENT OF DIABETES | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-06-05 | — | — | US | claimed |
| US-4132795-A | Benzenesulfonyl ureas and their use for the treatment of diabetes mellitus | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-01-02 | — | — | US | claimed |
| US-4029666-A | Benzenesulfonyl-ureas and process for preparing them | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-06-14 | — | — | US | claimed |
| US-4025519-A | HYPOGLYCEMIC AGENTS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-24 | — | — | US | claimed |
| US-3998968-A | Benzenesulfonyl ureas and process for their manufacture | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-12-21 | — | — | US | claimed |
| US-3962244-A | LOWERING OF BLOOD-SUGAR LEVELS | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | claimed |
| US-3961067-A | Composition comprising a benzenesulfonylurea hypoglycemic agent and method of treatment | PFIZER INC. (US) | 1976-06-01 | — | — | US | claimed |
| US-3961065-A | HYPOGLYCEMIC AGENTS | PFIZER INC. (US) | 1976-06-01 | — | — | US | claimed |
| US-3942973-A | Herbicidal compositions containing para-substituted benzenesulfonylureas and salts thereof and methods of employing such compositions | THE O. M. SCOTT & SONS COMPANY (US) | 1976-03-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230301946-A1 | THROMBOXANE RECEPTOR ANTAGONIST FORMULATIONS | TBXA2R, TBXAS1, UTS2R | CA2 3791/4885MMP2 2296/4885CA1 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.